Clinical trial
Terbinafine Compared to Griseofulvin in Children With Tinea Capitis
NCT00117767 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00117767 |
|---|---|
| Title | Terbinafine Compared to Griseofulvin in Children With Tinea Capitis |
| Official title | Efficacy and Safety of Terbinafine Compared to Griseofulvin in Children With Tinea Capitis |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Tinea Capitis |
| Intervention type | Drug |
| Interventions | Terbinafine hydrochloride (HCl), Griseofulvin |
| Enrollment | 720 |
| Start date | Jun 1, 2004 |
| Primary completion | Mar 1, 2006 |
| First posted | Jul 8, 2005 |
| Last update posted | May 31, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: